Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 90 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1862. Clear
Clear
Q3
TIBER CREEK GROUP for INCYTE CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q3
TIBER CREEK GROUP for EMD SERONO, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
TIBER CREEK GROUP for ASTRAZENECA
3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View →
Q3
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q3
THE NICKLES GROUP, LLC for MERCK & CO. INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q3
THE NICKLES GROUP, LLC for UCB, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Georgia · House · Senate · $60,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)
View →
Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
EMD SERONO, INC. for EMD SERONO INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q2
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code
View →
Q2
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues
View →
Q2
SPLITOAK STRATEGIES LLC for JOHNSON & JOHNSON SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q2
SPLITOAK STRATEGIES LLC for BRISTOL-MYERS SQUIBB
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Medicare/Medicaid
View →
Q2
SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q2
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
AVENUE SOLUTIONS for MODERNA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View →
Q2
AVENUE SOLUTIONS for MERCK & CO. INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q2
AVENUE SOLUTIONS for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
AVENUE SOLUTIONS for GENENTECH USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
INCYTE CORPORATION for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q2
AARP for AARP
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy, Family issues/Abortion/Adoption
View →
Q2
TIBER CREEK GROUP for DAIICHI SANKYO, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View →
Previous Page 3 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem